The Nuances of Immunotherapy Biomarker Testing in Solid Tumors

preview_player
Показать описание
  1. PeerView Oncology
  2. Dr. Hossein Borghaei
  3. Dr. Sanjay Mukhopadhyay
  4. Dr. Jonathan A. Nowak
  5. CME
  6. meded
Рекомендации по теме
The Nuances of 1:03:55

The Nuances of Immunotherapy Biomarker Testing in Solid Tumors

Revisiting PD-L1 as 1:33:59

Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum

Gaining Confidence in 0:56:08

Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies

Circulating Tumor DNA 0:28:57

Circulating Tumor DNA as an Immunotherapy Biomarker

Tumor mutation burden 0:04:12

Tumor mutation burden as a biomarker in NSCLC

Dr. Hamid on 0:01:15

Dr. Hamid on TMB as a Biomarker for Immunotherapy Response in Melanoma

Webinar recording on 1:01:24

Webinar recording on Biomarkers of Immunotherapy For Solid Tumors - Dr Nirmal Raut & Dr G Arun K...

Educational Sessions: 'Immunotherapy 0:28:29

Educational Sessions: 'Immunotherapy in the metastatic setting - chemo backbone and biomarker&a...

STS Webinar: Biomarker 0:46:42

STS Webinar: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC

Drs. Cottrell & 1:05:35

Drs. Cottrell & Sholl discuss #Immunotherapy updates at #USCAP2023 - https://bit.ly/3mKIJyK

Combinatorial Immunotherapy Approaches 1:05:11

Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors

PATHway to Decoding 0:49:36

PATHway to Decoding the Impact of Cancer Immunotherapy

Meeting of the 0:40:28

Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung ...

New Frontiers in 1:18:10

New Frontiers in Precision Immuno-Oncology

S2 Episode 5: 0:30:04

S2 Episode 5: Immunotherapy, Next-Generation Sequencing, and Shared Decision-Making in the Treatm...

33 First Line 1:22:53

33 First Line Therapy for HER2- PDL1+ GEA

Ask the Expert: 0:36:23

Ask the Expert: Laura Jacobsen, MD, University of Florida

Case 2: Biomarkers 0:08:45

Case 2: Biomarkers and Treatment Decisions in Stage IV NSCLC

Cancer Patient Lab 1:07:45

Cancer Patient Lab Meeting #75 - “Predicting Immunotherapy Response with a New Test' (BostonGen...

Tissue Biomarker Analysis: 0:30:53

Tissue Biomarker Analysis: A Practical Approach for Translational Research

Enhancing the Treatment 1:37:30

Enhancing the Treatment of HR NMIBC with Immunotherapy-Based Regimens_366418.06

Dr. Polsky on 0:01:13

Dr. Polsky on Using ctDNA as a Biomarker for Melanoma

Do You Order 0:02:27

Do You Order PD-L1 Testing Before Choosing an Immune Checkpoint Inhibitor?

Neoadjuvant Immune Checkpoint 0:15:22

Neoadjuvant Immune Checkpoint Inhibition for Muscle Invasive Bladder Cancer